Physician profile
Robert A Forbes, JR.
NPI 1245279009
$681.12
in general payments reported to CMS, 2019-2025
18 companies · $130 in 2025
The $130 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $106 · 2023: $183 · 2024: $140 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $100.27 | 2019-2024 | Adzenys Xr-Odt |
| Ironshore Pharmaceuticals INC. | $92.42 | 2019-2023 | Jornay Pm |
| Corium, LLC | $89.41 | 2023-2025 | Azstarys |
| Cranial Technologies, INC | $60.55 | 2019-2025 | Doc Band |
| Pfizer INC. | $47.37 | 2023-2025 | |
| Sobi, INC | $38.67 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.42 | 2019-2020 | |
| Shire North American Group INC | $29.02 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.61 | 2025 | |
| Genzyme Corporation | $22.47 | 2023 | |
| Phadia US INC. | $21.70 | 2024 | Immunocap |
| Astrazeneca Pharmaceuticals LP | $20.11 | 2023 | Flumist Quadrivalent |
| Glaxosmithkline, LLC. | $18.79 | 2023 | Bexsero |
| Tris Pharma INC | $18.48 | 2020 | |
| Seqirus USA INC | $17.82 | 2024 | Flucelvax |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $17.37 | 2025 | Relexxii |
| Lnhc, INC | $17.14 | 2025 | Zelsuvmi |
| Supernus Pharmaceuticals, INC. | $16.50 | 2024 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Forbes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.